MELEDDU, RITA
 Distribuzione geografica
Continente #
EU - Europa 177.888
NA - Nord America 5.101
AS - Asia 1.787
SA - Sud America 286
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 185.185
Nazione #
IT - Italia 176.416
US - Stati Uniti d'America 5.026
CN - Cina 827
SG - Singapore 650
SE - Svezia 377
UA - Ucraina 377
DE - Germania 258
BR - Brasile 241
FI - Finlandia 122
GB - Regno Unito 117
VN - Vietnam 89
MA - Marocco 79
FR - Francia 57
IN - India 50
KR - Corea 43
CA - Canada 37
HK - Hong Kong 32
AT - Austria 27
MX - Messico 27
NL - Olanda 25
RU - Federazione Russa 22
BD - Bangladesh 19
PL - Polonia 19
ZA - Sudafrica 19
PK - Pakistan 17
AR - Argentina 16
BE - Belgio 13
ES - Italia 12
CZ - Repubblica Ceca 11
IE - Irlanda 10
TR - Turchia 10
ID - Indonesia 9
JP - Giappone 8
CO - Colombia 7
EC - Ecuador 6
PT - Portogallo 6
PY - Paraguay 6
IR - Iran 5
TN - Tunisia 5
VE - Venezuela 5
EG - Egitto 4
IQ - Iraq 4
KE - Kenya 4
PA - Panama 4
UZ - Uzbekistan 4
CL - Cile 3
EU - Europa 3
JO - Giordania 3
LT - Lituania 3
NP - Nepal 3
SA - Arabia Saudita 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
ET - Etiopia 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
KG - Kirghizistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
ME - Montenegro 1
NG - Nigeria 1
PH - Filippine 1
SL - Sierra Leone 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 185.185
Città #
Cagliari 173.421
Uta 2.658
Ashburn 463
Fairfield 463
Woodbridge 399
Chandler 348
Dallas 344
Singapore 293
Nyköping 261
Houston 247
Ann Arbor 238
Wilmington 224
Seattle 206
Boardman 205
Jacksonville 183
Beijing 175
Cambridge 149
Dearborn 136
New York 116
Shanghai 93
Los Angeles 91
Santa Clara 81
Casablanca 77
Nanjing 75
Boston 57
Helsinki 56
Hefei 50
The Dalles 45
Seoul 43
Munich 40
Redwood City 34
San Diego 31
Verona 30
Buffalo 29
Ho Chi Minh City 29
Hong Kong 29
Shenyang 26
Dong Ket 24
Milan 24
São Paulo 22
Amsterdam 21
Vienna 21
Changsha 20
Nanchang 19
Guangzhou 18
Chennai 17
Frankfurt am Main 17
Redondo Beach 17
Warsaw 17
Jiaxing 16
Sassari 16
Toronto 16
Hebei 15
London 15
Herndon 14
Jinan 13
Mountain View 13
Tianjin 13
Zhengzhou 13
Council Bluffs 12
Phoenix 12
Brussels 11
Chicago 11
Gujranwala 11
Hanoi 11
Kunming 11
Norwalk 11
Nuremberg 11
Mexico City 10
Brooklyn 9
Dublin 9
Rio de Janeiro 9
Atlanta 8
Auburn Hills 8
Johannesburg 8
Montreal 8
San Francisco 8
Turku 8
Washington 8
Wuhan 8
Denver 7
Ningbo 7
Rome 7
Tokyo 7
Bengaluru 6
Brno 6
Columbus 6
Düsseldorf 6
Guarulhos 6
Hangzhou 6
Jakarta 6
Lauterbourg 6
Orange 6
Paris 6
Walnut 6
Zerfalìu 6
Campinas 5
Durban 5
Falls Church 5
Lappeenranta 5
Totale 182.148
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.687
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.025
Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders 4.652
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.628
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.481
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors 4.406
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.344
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.290
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.273
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.143
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 3.897
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold 3.733
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.730
Ferulic Acid Esters and Withanolides: in Search of Withania somnifera GABAA Receptor Modulators 3.551
Targeting tumor associated carbonic anhydrase IX and XII: Highly isozyme selective coumarin and psoralen inhibitors 3.505
Systemic lupus erythematosus occurring in a patient with Niemann-Pick type B disease. 3.501
Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation 3.375
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.332
Design and synthesis of new isatin derivatives as HIV-1 reverse transcriptase associated ribonuclease H inhibitors 3.282
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.277
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.226
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.176
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.155
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.002
Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids 2.987
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides 2.983
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.931
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.878
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.869
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.737
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.595
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.579
Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases 2.514
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.415
New promising scaffolds for the inhibition of monoamine oxidase B 2.268
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.217
Design and synthesis of new Isatin derivatives as HIV-1 Reverse Transcriptase associated Ribonuclease H inhibitors twenty-fourth 2.122
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.096
Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis 2.074
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.043
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 1.974
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.929
1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis and microbiological evaluation 1.929
Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones 1.883
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.846
1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings 1.798
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.765
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.755
New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII 1.693
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.670
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.655
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey 1.602
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.579
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.578
Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis 1.576
Novel N-aryl- and N-heteryl-phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and MDR Mycobacterium tuberculosis 1.529
From classic to innovative approaches in HIV-1 infection treatment 1.521
Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis 1.480
2-methoxynaphthalen thiazole derivate : a new HIV-1 RT Ribonuclease H/DNA polymerase dual inhibitor active on viral replication 1.471
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.137
Synthesis, molecular modelling, inhibitory acivity, and selectivity towards monoamine oxidase of new heterocyclic scaffold 1.080
Design and synthesis of 1,5-diaryl-2-ethyl pyrrole derivatives and their evaluation as antimycobacterial agents 1.055
L’OLIO ESSENZIALE DI ARTEMISIA ARBORESCENS INATTIVA HSV1 E HSV2 E INIBISCE LA DIFFUSIONE LATERALE DI CELLULE VERO 970
Synthesis of different series of small molecules targeting HIV-1 RT, Candida albicans, MAO and G-Quadruplex 963
Tri-substituted thiazolines as promising scaffolds for the design of efficient COX inhibitors 896
5-Nitro-3-(2-(4-phenylthiazol-2-yl)hydrazineylidene)indolin-2-one derivatives inhibit HIV-1 replication by a multitarget mechanism of action 832
L’olio essenziale di Artemisia arborescens inattiva HSV-1 e HSV-2 e inibisce la diffusione laterale in cellule Vero 764
Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives 710
Suppression of lipopolysaccharide-induced COX-2 expression via p38MAPK, JNK, and C/EBPβ phosphorylation inhibition by furomagydarin A, a benzofuran glycoside from Magydaris pastinacea 591
2H-chromene and 7H-furo-chromene derivatives selectively inhibit tumour associated human carbonic anhydrase IX and XII isoforms 382
Privileged Scaffold Hybridization in the Design of Carbonic Anhydrase Inhibitors 228
New Structural Features of Isatin Dihydrothiazole Hybrids for Selective Carbonic Anhydrase Inhibitors 227
Exploring the 1-(4-Nitrophenyl)-3-arylprop-2-en-1-one Scaffold for the Selective Inhibition of Monoamine Oxidase B 208
Synthesis and Evaluation of Thiazolidinone-Isatin Hybrids for Selective Inhibition of Cancer-Related Carbonic Anhydrases 98
Tiazolidinoni come agenti antivirali 96
Totale 185.449
Categoria #
all - tutte 211.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 211.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116.992 0 0 0 0 0 4.124 3.003 2.371 1.146 2.434 2.581 1.333
2021/20228.064 1.004 734 401 542 710 557 445 382 689 764 894 942
2022/202312.945 1.117 1.853 1.685 1.379 868 1.346 675 1.036 762 691 1.076 457
2023/202411.424 523 367 816 816 1.081 2.108 1.464 934 723 706 858 1.028
2024/202536.787 13.803 11.583 4.410 2.369 1.081 1.764 831 114 261 184 147 240
2025/20262.607 471 253 755 549 535 44 0 0 0 0 0 0
Totale 185.449